Federal Register / Vol. 77, No. 11 / Wednesday, January 18, 2012 / Notices 2549 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Grants for 

Injury Control Research Centers (Panel 

3), Funding Opportunity 

Announcement (FOA) CE12–001, Initial 

Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned SEP: 

Time and Date: 8:30 a.m.–5 p.m., February 

21–22, 2012 (Closed). 

Place: Crowne Plaza Atlanta Perimeter 

Hotel at Ravinia, 4355 Ashford Dunwoody 

Rd, Atlanta, Georgia 30346 Telephone: (770) 

395–7700. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c) (4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include the initial review, discussion, and 

evaluation of applications received in 

response to ‘‘Grants for Injury Control 

Research Centers, Panel 3, FOA CE12–001.’’ 

Contact Person for More Information: 

Donald Blackman, Ph.D., M.P.H., Scientific 

Review Officer, CDC, 4770 Buford Highway 

NE., Mailstop F63, Atlanta, Georgia 30341, 

Telephone (770) 488–0641. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: January 11, 2012. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2012–842 Filed 1–17–12; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Grants for 

Injury Control Research Centers (Panel 

1), Funding Opportunity 

Announcement (FOA) CE12–001, Initial 

Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned SEP: 

Time and Date: 8:30 a.m.–5 p.m., February 

21–22, 2012 (Closed). 

Place: Crowne Plaza Atlanta Perimeter 

Hotel at Ravinia, 4355 Ashford Dunwoody 

Road, Atlanta, Georgia 30346 Telephone: 

(770) 395–7700. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c) (4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include the initial review, discussion, and 

evaluation of applications received in 

response to ‘‘Grants for Injury Control 

Research Centers, Panel 1, FOA CE12–001.’’ 

Contact Person for More Information: J. 

Felix Rogers, Ph.D., M.P.H., Scientific 

Review Officer, CDC, 4770 Buford Highway 

NE., Mailstop F63, Atlanta, Georgia 30341, 

Telephone (770) 488–4334. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: January 11, 2012. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2012–848 Filed 1–17–12; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee to the Director 

(ACD), Centers for Disease Control and 

Prevention (CDC)—Ethics 

Subcommittee (ES) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the CDC announces 

the following meeting of the 

aforementioned subcommittee: 

Dates and Times: 

February 9, 2012, 1 p.m.–5 p.m. 

February 10, 2012, 8:30 a.m.–12:30 p.m. 

Place: CDC, Thomas R. Harkin Global 

Communications Center, Auditorium B–3, 

1600 Clifton Road, NE., Atlanta, Georgia 

30333. This meeting is also available by 

teleconference. Please dial (877) 928–1204 

and enter code 4305992. 

Status: Open to the public, limited only by 

the space available. The meeting room 

accommodates approximately 200 people. To 

accommodate public participation in the 

meeting, a conference telephone line will be 

available. The public is welcome to 

participate during the public comment 

period. The public comment periods are 

tentatively scheduled for 4:30 p.m.–4:45 p.m. 

on February 9, 2012 and from 12 p.m.–12:15 

p.m. on February 10, 2012. 

Purpose: The ES will provide counsel to 

the ACD, CDC, regarding a broad range of 

public health ethics questions and issues 

arising from programs, scientists and 

practitioners. 

Matters To Be Discussed: Agenda items 

will include the following: Progress on 

developing practical tools to assist state, 

tribal, local, and territorial health 

departments in their efforts to address public 

health ethics challenges, approaches for 

evaluating the impact of public health ethics, 

strategies for increasing collaboration 

between public health ethics and public 

health law, and updates on CDC efforts to 

build national and international 

collaboration on public health ethics. 

The agenda is subject to change as 

priorities dictate. 

Contact Person for More Information: For 

security reasons, members of the public 

interested in attending the meeting should 

contact Drue Barrett, Ph.D., Designated 

Federal Officer, ACD, CDC–ES, 1600 Clifton 

Road NE., M/S D–50, Atlanta, Georgia 30333. 

Telephone: (404) 639–4690. Email: 

dbarrett@cdc.gov. The deadline for 

notification of attendance is February 3, 

2012. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: January 11, 2012. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2012–835 Filed 1–17–12; 8:45 am] 

BILLING CODE 4163–18–P 


tkelley on DSK3SPTVN1PROD with NOTICES